MabSpace and HJB have formed a new biotherapeutics organization dubbed Transcenta Holding.
A political deadlock that led to a partial government shutdown before Christmas could take some of the shine off a golden year of FDA approvals.
Novotech adds Oracle’s Trial Management and Monitoring Cloud Service to support its work in the Asia-Pacific region.
WuXi AppTec shares firm some a week after the company debuted its IPO on the Hong Kong exchange.
Pharmaceutical Product Development is adding more punch to its therapeutics offerings with new leadership.
AstraZeneca is partnering with Cancer Research UK to debut a new research facility that will focus on using CRISPR and other functional genomics tech.
Target PharmaSolutions announced a pair of partnerships that includes Gilead and Bristol-Myers Squibb.
TrialSpark launches its first clinical trial sites as part of a partnership with Novartis that takes a new direction.
Parexel partnering with Eli Lilly to support building a clinical trial learning and development program in China.
The acquisition is expected to bolster Biotage’s presence as a separations company within the growing biomolecule arena.